We are live on ! Find out more
AAF

Andra AP-fonden Portfolio holdings

AUM $8.39B
1-Year Est. Return 21.19%
This Fund
S&P 500
This Quarter Est. Return
+1.92%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
10 Year Est. Return
AUM
$5.95B
AUM Growth
+$319M
Cap. Flow
+$251M
Cap. Flow %
4.22%
Top 10 Hldgs %
16.32%
Holding
451
New
88
Increased
179
Reduced
148
Closed
36

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$55.3M
2
AVGO icon
Broadcom
AVGO
+$42.3M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$29.8M
4
MSFT icon
Microsoft
MSFT
+$27M
5
HD icon
Home Depot
HD
+$26.7M

Sector Composition

Rank Sector Weight
1 Technology 32.56%
2 Healthcare 14.4%
3 Consumer Discretionary 10.02%
4 Financials 9.97%
5 Industrials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSX icon
151
CSX Corp
CSX
$94.5B
$13.4M 0.23%
401,400
-38,700
-9% -$1.31M
UHS icon
152
Universal Health Services
UHS
$10.2B
$13.4M 0.23%
72,600
-13,400
-16% -$2.37M
AMT icon
153
American Tower
AMT
$81.7B
$13.4M 0.23%
68,900
-7,200
-9% -$1.35M
WAT icon
154
Waters Corp
WAT
$38.9B
$13.3M 0.22%
45,940
+6,600
+17% +$2.11M
FCNCA icon
155
First Citizens BancShares
FCNCA
$25.6B
$13.1M 0.22%
7,800
+1,000
+15% +$1.67M
TW icon
156
Tradeweb Markets
TW
$21.4B
$13.1M 0.22%
123,800
+32,400
+35% +$3.42M
ACGL icon
157
Arch Capital
ACGL
$33.9B
$13.1M 0.22%
+129,600
New +$12.6M
CCI icon
158
Crown Castle
CCI
$33.9B
$13M 0.22%
133,500
+18,900
+16% +$1.86M
CVS icon
159
CVS Health
CVS
$133B
$12.9M 0.22%
219,100
-29,200
-12% -$1.83M
AMP icon
160
Ameriprise Financial
AMP
$48.9B
$12.9M 0.22%
30,100
+5,300
+21% +$2.26M
TEAM icon
161
Atlassian
TEAM
$28B
$12.7M 0.21%
72,000
+8,500
+13% +$1.52M
MA icon
162
Mastercard
MA
$500B
$12.7M 0.21%
28,800
+7,100
+33% +$3.23M
PH icon
163
Parker-Hannifin
PH
$125B
$12.7M 0.21%
25,100
+14,500
+137% +$7.78M
CPT icon
164
Camden Property Trust
CPT
$11B
$12.6M 0.21%
115,700
+12,300
+12% +$1.27M
PKG icon
165
Packaging Corp of America
PKG
$22.8B
$12.6M 0.21%
69,000
-8,200
-11% -$1.49M
CLX icon
166
Clorox
CLX
$12.7B
$12.4M 0.21%
91,200
+32,100
+54% +$4.46M
ENPH icon
167
Enphase Energy
ENPH
$5.52B
$12.3M 0.21%
123,700
+99,442
+410% +$11.6M
C icon
168
Citigroup
C
$230B
$12.3M 0.21%
+194,200
New +$12M
EG icon
169
Everest Group
EG
$14.2B
$12.3M 0.21%
+32,200
New +$12.2M
FTNT icon
170
Fortinet
FTNT
$123B
$12M 0.2%
199,900
-76,000
-28% -$4.73M
CAT icon
171
Caterpillar
CAT
$404B
$12M 0.2%
36,000
+1,000
+3% +$347K
VEEV icon
172
Veeva Systems
VEEV
$34.4B
$11.5M 0.19%
63,000
+33,100
+111% +$6.57M
ESS icon
173
Essex Property Trust
ESS
$18.5B
$11.2M 0.19%
41,300
-3,700
-8% -$950K
GLPI icon
174
Gaming and Leisure Properties
GLPI
$12.6B
$11.2M 0.19%
247,500
+74,200
+43% +$3.28M
UTHR icon
175
United Therapeutics
UTHR
$22B
$11.2M 0.19%
35,100
+1,900
+6% +$503K

Similar funds

Andra AP-fonden's Q2 2024 Portfolio in Review

As of Q2 2024, Andra AP-fonden held 451 positions worth $5.95B, up 5.7% from $5.63B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Andra AP-fonden deployed $251M of net new capital in Q2 2024, opening 88 new positions and adding to 179 existing holdings. Its largest new stake was Accenture: 115,208 shares worth $35M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Broadcom, an estimated $42.3M trimmed.

  • Andra AP-fonden's largest Q2 2024 buy was Accenture: 115,208 shares worth $35M.
  • Andra AP-fonden added most to Johnson & Johnson in Q2 2024, an estimated $40.5M increase.
  • Andra AP-fonden's biggest Q2 2024 reduction was Broadcom, cutting an estimated $42.3M.
  • Andra AP-fonden fully exited Bristol-Myers Squibb in Q2 2024, selling an estimated $55.3M.
  • Andra AP-fonden's ten largest holdings make up 16% of its $5.95B portfolio in Q2 2024.
  • Andra AP-fonden opened 88 new positions and closed 36 in Q2 2024.
  • Andra AP-fonden's portfolio value rose 5.7% quarter-over-quarter to $5.95B.

Based on Andra AP-fonden's 13F filing for Q2 2024, filed 7 Aug 2024.